Literature DB >> 19922565

Anabolic-androgenic steroid dependence: an emerging disorder.

Gen Kanayama1, Kirk J Brower, Ruth I Wood, James I Hudson, Harrison G Pope.   

Abstract

AIMS: Anabolic-androgenic steroids (AAS) are widely used illicitly to gain muscle and lose body fat. Here we review the accumulating human and animal evidence showing that AAS may cause a distinct dependence syndrome, often associated with adverse psychiatric and medical effects.
METHOD: We present an illustrative case of AAS dependence, followed by a summary of the human and animal literature on this topic, based on publications known to us or obtained by searching the PubMed database.
RESULTS: About 30% of AAS users appear to develop a dependence syndrome, characterized by chronic AAS use despite adverse effects on physical, psychosocial or occupational functioning. AAS dependence shares many features with classical drug dependence. For example, hamsters will self-administer AAS, even to the point of death, and both humans and animals exhibit a well-documented AAS withdrawal syndrome, mediated by neuroendocrine and cortical neurotransmitter systems. AAS dependence may particularly involve opioidergic mechanisms. However, AAS differ from classical drugs in that they produce little immediate reward of acute intoxication, but instead a delayed effect of muscle gains. Thus standard diagnostic criteria for substance dependence, usually crafted for acutely intoxicating drugs, must be adapted slightly for cumulatively acting drugs such as AAS.
CONCLUSIONS: AAS dependence is a valid diagnostic entity, and probably a growing public health problem. AAS dependence may share brain mechanisms with other forms of substance dependence, especially opioid dependence. Future studies are needed to characterize AAS dependence more clearly, identify risk factors for this syndrome and develop treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922565      PMCID: PMC2780436          DOI: 10.1111/j.1360-0443.2009.02734.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  134 in total

1.  Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys.

Authors:  Sean Esteban McCabe; Kirk J Brower; Brady T West; Toben F Nelson; Henry Wechsler
Journal:  Drug Alcohol Depend       Date:  2007-05-23       Impact factor: 4.492

2.  Anabolic steroid dependence with opioid-type features.

Authors:  F Tennant; D L Black; R O Voy
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

Review 3.  Steroid modulation of GABAA receptor-mediated transmission in the hypothalamus: effects on reproductive function.

Authors:  Leslie P Henderson
Journal:  Neuropharmacology       Date:  2007-02-28       Impact factor: 5.250

4.  Abuse liability of testosterone.

Authors:  M I Fingerhood; J T Sullivan; M Testa; D R Jasinski
Journal:  J Psychopharmacol       Date:  1997       Impact factor: 4.153

Review 5.  Anabolic androgenic steroids and forebrain GABAergic transmission.

Authors:  L P Henderson; C A A Penatti; B L Jones; P Yang; A S Clark
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

6.  Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.

Authors:  N P Boyadjiev; K N Georgieva; R I Massaldjieva; S I Gueorguiev
Journal:  J Sports Med Phys Fitness       Date:  2000-09       Impact factor: 1.637

Review 7.  Impulsivity as a determinant and consequence of drug use: a review of underlying processes.

Authors:  Harriet de Wit
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

8.  Anabolic steroid users' attitudes towards physicians.

Authors:  Harrison G Pope; Gen Kanayama; Martin Ionescu-Pioggia; James I Hudson
Journal:  Addiction       Date:  2004-09       Impact factor: 6.526

9.  Effects of nandrolone on acute morphine responses, tolerance and dependence in mice.

Authors:  Evelyne Célérier; Maryam T Yazdi; Anna Castañé; Sandy Ghozland; Fred Nyberg; Rafael Maldonado
Journal:  Eur J Pharmacol       Date:  2003-03-28       Impact factor: 4.432

10.  Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  Sanna Kurling; Aino Kankaanpää; Timo Seppälä
Journal:  Behav Brain Res       Date:  2008-01-05       Impact factor: 3.332

View more
  59 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

2.  Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson
Journal:  Biol Psychiatry       Date:  2011-08-12       Impact factor: 13.382

3.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

Review 4.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

5.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

6.  The influence of age of onset and acute anabolic steroid exposure on cognitive performance, impulsivity, and aggression in men.

Authors:  Tom Hildebrandt; James W Langenbucher; Adrianne Flores; Seth Harty; Heather A Berlin; Heather Berlin
Journal:  Psychol Addict Behav       Date:  2014-05-19

7.  The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates.

Authors:  Harrison G Pope; Gen Kanayama; Alison Athey; Erin Ryan; James I Hudson; Aaron Baggish
Journal:  Am J Addict       Date:  2013-09-20

8.  Iatrogenic dependence of anabolic-androgenic steroid in an Indian non-athletic woman.

Authors:  Adarsh Tripathi; Bheemsain Tekkalaki; Shashwat Saxena; Himanshu Dandu
Journal:  BMJ Case Rep       Date:  2014-02-06

9.  Cognitive deficits in long-term anabolic-androgenic steroid users.

Authors:  Gen Kanayama; Joseph Kean; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2012-12-14       Impact factor: 4.492

10.  Enhancement drugs: are there limits to what we should enhance and why?

Authors:  Morten Hesse
Journal:  BMC Med       Date:  2010-08-03       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.